Shigehira Saji

基本信息

浏览量：298

职业迁徙

个人简介

Shigetaka Saji His main interest is low-mass X-ray binaries. Also, he is concerned with a development of Hard XrayTelescopes onboard ASTRO-H.

研究兴趣

论文共 307 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Japanese Breast Cancer Society Clinical Practice Guidelines for Epidemiology and Prevention of Breast Cancer, 2022 Edition

Masaaki Kawai,Shoichiro Ohtani,Motoki Iwasaki,Seiichiro Yamamoto,Kiyoshi Takamatsu,Hitoshi Okamura,Masami Arai,Tsunehisa Nomura,Shinji Ozaki,Ken-ichi Shibata, Ayaka Akabane,Fuyuhiko Motoi,Chikako Yamauchi,Yutaka Yamamoto,Hiroji Iwata,Shigehira Saji

BREAST CANCERno. 2 (2024): 166-178

引用0浏览0WOS引用

[Improved Outcomes in Advanced Metastatic Breast Cancer]

Shigehira Saji

Gan to kagaku ryoho Cancer & chemotherapyno. 3 (2024): 250-253

引用0浏览0WOS引用

Abstract PO1-05-06: Health-related QOL and Physical Activity Collected Via Wearable Device in Patients with HR+/HER2− Advanced Breast Cancer in Japan Treated with Palbociclib+endocrine Therapy (ET) or ET Alone: 6-Month Longitudinal Study (JBCRG-26)

Hiroko Bando,Mari Oba,Aya Ueda,Kaori Terata,Mihoko Doi,Shigenori Nagai,Masaya Hattori,Ken-Ichi Watanabe,Nobuko Tamura,Manabu Futamura,Kei Koizumi,Naoki Niikura,Tempei Miyaji,Yasuaki Muramatsu,Linghua Xu,Norikazu Masuda,Shigehira Saji

Cancer Researchno. 9_Supplement (2024): PO1-05

引用0浏览0引用

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results

CLINICAL CANCER RESEARCHno. 4 (2024): 767-778

引用0浏览0WOS引用

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment (vol 31, pg 340, 2024)

Yutaka Yamamoto,Chikako Yamauchi,Tatsuya Toyama,Shigenori Nagai,Takehiko Sakai,Goro Kutomi,Michio Yoshimura,Masaaki Kawai,Shoichiro Ohtani,Kazunori Kubota,Kazutaka Nakashima,Naoko Honma,Masayuki Yoshida,Eriko Tokunaga,Naruto Taira,Hiroji Iwata,Shigehira Saji

BREAST CANCER (2024)

引用0浏览0引用

Real-world Data of HER2-negative Early Breast Cancer Patients Treated with Anthracycline And/or Taxane Regimens in Japan

Akihiko Shimomura,Yasuaki Sagara,Ryo Koto, Masakazu Fujiwara, Yuka Kanemura, Hiroshi Kitagawa,Shigehira Saji

Breast Cancer（2024）

引用0浏览0WOS引用

The Japanese Breast Cancer Society Clinical Practice Guidelines for Radiation Treatment of Breast Cancer, 2022 Edition

Michio Yoshimura,Chikako Yamauchi,Naoko Sanuki,Yasushi Hamamoto,Kimiko Hirata,Jiro Kawamori,Mariko Kawamura,Mami Ogita,Yutaka Yamamoto,Hiroji Iwata,Shigehira Saji

Breast Cancerno. 3 (2024): 347-357

引用0浏览0WOS引用

Innovation of the First-Line Strategy Optimized As Abemaciclib with Endocrine Therapy Based on the ESR1mutation of Ctdna for Patients with HR-positive HER2-negative Advanced Metastatic Breast Cancer (JBCRG-M08; AMBER Study)

Tetsuhiro Yoshinami,Shinsuke Sasada,Meiko Nishimura,Madoka Iwase,Chiya Oshiro,Kaori Terata,Mikiya Ishihara,Hiroko Bando,Masahiko Tanabe,Nobuyasu Yoshimoto,Sayuri Akiyoshi,Masahiro Takada,Hiroshi Ishiguro,Shigehira Saji,Satoshi Morita,Norikazu Masuda

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

助理教授

论文共 307 篇作者统计合作学者相似作者